Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)

Novo Nordisk · Phase 3 · Completed · Enrollment 153

NCT01234649

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Metformin XR plus liraglutiden/rn/rn/rn/r
Metformin XR plus placebon/rn/rn/rn/r

Not shown

  • Metformin XR plus liraglutide: endpoint not reported
  • Metformin XR plus placebo: endpoint not reported